Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker

Forkhead box Q1 (FOXQ1) is a member of the forkhead transcription factor family involved in the occurrence and development of different tumors. However, the specific expression patterns and functions of FOXQ1 in pan-cancer remain unclear. Therefore, we collected the expression, mutation, and clinica...

Full description

Bibliographic Details
Main Authors:	Qiguan Dong, Lirong Yan, Qingbang Xu, Xianliang Hu, Yan Yang, Ruiwu Zhu, Qian Xu, Yuchao Yang, Bengang Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Genetics
Subjects:	FOXQ1 prognosis tumor mutational burden microsatellite instability tumor microenvironment immune cell infiltration
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.944970/full

Similar Items

Forkhead Box Q1 Is Critical to Angiogenesis and Macrophage Recruitment of Colorectal Cancer
by: Hui Tang, et al.
Published: (2020-11-01)

Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer
by: Liping Wang, et al.
Published: (2022-12-01)

Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy
by: Chengfei Xu, et al.
Published: (2023-02-01)

KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer
by: Chunhua Ni, et al.
Published: (2024-04-01)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
by: He J, et al.
Published: (2022-11-01)

Identification and Development of Subtypes with Poor Prognosis in Gastric Cancer Based on Both Hypoxia and Immune Cell Infiltration
by: Wang Y, et al.
Published: (2021-12-01)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
by: Cheng Zeng, et al.
Published: (2022-08-01)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
by: Rongrong Xie, et al.
Published: (2022-03-01)

The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis
by: Wei Wei, et al.
Published: (2023-12-01)

Subtyping of microsatellite instability-high colorectal cancer
by: Wangxiong Hu, et al.
Published: (2019-07-01)

Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
by: Giuseppe Palmieri, et al.
Published: (2021-05-01)

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
by: Xiaobin Zheng, et al.
Published: (2023-07-01)

Integrative Genomic Tests in Clinical Oncology
by: Evgeny Imyanitov, et al.
Published: (2022-10-01)

Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon Cancers and 5-FU Resistance
by: Zhongze Cui, et al.
Published: (2023-04-01)

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
by: Daniela Gabbia, et al.
Published: (2023-02-01)

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
by: Chiao-En Wu, et al.
Published: (2020-11-01)

MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability
by: Peng Jia, et al.
Published: (2020-02-01)

Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma
by: Elizabeth A. Bloom, et al.
Published: (2023-01-01)

SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
by: Yue Li, et al.
Published: (2022-11-01)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
by: Zhang Meijing, et al.
Published: (2022-06-01)

Nuclear Akt promotes neurite outgrowth in the early stage of neuritogenesis
by: Ji Hye Park1,2,3#, Sang Bae Lee1,#, Kyung-Hoon Lee2,3,* & Jee-Yin Ahn1,3,*
Published: (2012-09-01)

The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy
by: Jing Yi Lee, et al.
Published: (2022-07-01)

Mismatch repair status and high expression of PD-L1 in nasopharyngeal carcinoma
by: Zhao L, et al.
Published: (2019-02-01)

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
by: Ziyi Bai, et al.
Published: (2022-01-01)

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
by: Emilie Picard, et al.
Published: (2020-03-01)

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
by: Bao Jin, et al.
Published: (2023-10-01)

Tumor immune response and immunotherapy in gastric cancer
by: Yoonjin Kwak, et al.
Published: (2020-01-01)

NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability
by: Hui Wang, et al.
Published: (2022-07-01)

Beyond the Variants: Mutational Patterns in Next-Generation Sequencing Data for Cancer Precision Medicine
by: Megan Parilla, et al.
Published: (2020-05-01)

Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD
by: Chuanzhi Chen, et al.
Published: (2022-04-01)

Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity
by: Manuela Lizarralde-Guerrero, et al.
Published: (2024-12-01)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
by: Xiang-mei Wen, et al.
Published: (2021-10-01)

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications
by: Hendrien Kuipers, et al.
Published: (2021-10-01)

PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score
by: Yoon Ah Cho, et al.
Published: (2021-09-01)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
by: Samuel I. Kim, et al.
Published: (2021-02-01)

Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
by: Qing Zhang, et al.
Published: (2023-07-01)

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer
by: Haoran Li, et al.
Published: (2022-08-01)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
by: Wenming Lv, et al.
Published: (2022-09-01)

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
by: Mouhammed Amir Habra, et al.
Published: (2019-09-01)

Analytical validation and clinical utilization of K-4CARE™: a comprehensive genomic profiling assay with personalized MRD detection
by: Thien-Phuc Nguyen Hoang, et al.
Published: (2024-02-01)